COMPARISON OF BMI, LIPID PARAMETERS, AST, AND LDH IN MYOCARDIAL INFARCTION PATIENTS STRATIFIED BY SMOKING STATUS: A CASE-CONTROL STUDY PAKISTAN

Authors

  • Fakhre Islam Department of Community Medicine, Bannu Medical College, Medical Teaching Institution (MTI), Bannu, Khyber Pakhtunkhwa, Pakistan.
  • Qismat Ullah Department of Medicine, Khalifa Gul Nawaz Teaching Hospital, Medical Teaching Institution (MTI), Bannu, Khyber Pakhtunkhwa, Pakistan.
  • Farman Ullah Department of Pathology and Curative Medicine, Ittehad Medical & Diagnostic Complex (IMDC), Karak, Khyber Pakhtunkhwa, Pakistan.
  • Muhammad Bilal Shah Department of Community Medicine, Bannu Medical College, Medical Teaching Institution (MTI), Bannu, Khyber Pakhtunkhwa, Pakistan.
  • Ahmad Ehsan Rabani Department of Community Medicine, HBS Medical & Dental College, Islamabad, Pakistan.
  • Faisal Nadeem Department of Community Medicine, Bannu Medical College, Medical Teaching Institution (MTI), Bannu, Khyber Pakhtunkhwa, Pakistan.

DOI:

https://doi.org/10.67145/xbbn9670

Keywords:

myocardial infarction, smoking, dyslipidaemia, body mass index, aspartate aminotransferase, lactate dehydrogenase, Pakistan

Abstract

Background: Smoking and dyslipidaemia contribute to cardiovascular disease. This study compared BMI, lipid parameters, AST, and LDH in Pakistani myocardial infarction (MI) patients and controls stratified by smoking status.

Methods: A hospital-based case-control study enrolled 150 MI patients and 150 age-comparable controls at Khalifa Gul Nawaz Teaching Hospital, Medical Teaching Institution (MTI), Bannu, Khyber Pakhtunkhwa, Pakistan. Pakistan, from11 June 2025  to 20 October 2025. BMI and fasting serum biochemical parameters were assessed. Comparisons were stratified by smoking status and age. Exploratory correlations included 53 MI cases with complete data.

Results: BMI did not differ between MI patients and controls overall (p = 0.857). Total cholesterol and LDL were higher in MI patients across smoking strata. Among smokers, triglycerides were 215.50 ± 30.73 mg/dL in MI patients versus 155.92 ± 52.23 mg/dL in controls (p < 0.001), whereas the non-smoker comparison was not significant (p = 0.401). HDL was higher in MI patients overall and among non-smokers (both p < 0.001). LDH was higher in MI patients across strata (all p < 0.001). AST did not differ significantly between smoking cases and smoking controls (p = 0.103). In the complete-case subset, the HDL correlation among non-smokers met the nominal 0.05 threshold (r = −0.376, p = 0.037), whereas the LDH correlation among smokers did not (r = 0.414, p = 0.055).

Conclusion: MI patients showed differences in lipid and enzyme concentrations, with a marked triglyceride difference among smokers. These unadjusted comparisons do not establish independent smoking effects, causal mechanisms, or diagnostic accuracy. The unexpected HDL finding and exploratory correlations require cautious interpretation.

 

 

References

1. Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990–2023. J Am Coll Cardiol. 2025;86(22):2167–2243. https://doi.org/10.1016/j.jacc.2025.08.015

2. Abdul Jabbar AB, Mansoor T, Sheikh S, Jafar TH, Hanif S, Razo C, et al. Burden of cardiovascular disease in Pakistan—insight from Global Burden of Disease Study 2019. BMC Cardiovasc Disord. 2026;26(1):481. https://doi.org/10.1186/s12872-026-05733-9

3. Samad Z, Hanif B. Cardiovascular diseases in Pakistan: imagining a postpandemic, postconflict future. Circulation. 2023;147(17):1261–1263. https://doi.org/10.1161/CIRCULATIONAHA.122.059122

4. Ballena-Caicedo J, Zuzunaga-Montoya FE, Loayza-Castro JA, Vasquez-Romero LEM, Tapia-Limonchi R, De Carrillo CIG, et al. Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis. J Health Popul Nutr. 2025;44(1):308. https://doi.org/10.1186/s41043-025-01054-3

5. Seo YS, Park JM, Kim JH, Lee MY. Cigarette smoke-induced reactive oxygen species formation: a concise review. Antioxidants (Basel). 2023;12(9):1732. https://doi.org/10.3390/antiox12091732

6. Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014;64(16):1740–1750. https://doi.org/10.1016/j.jacc.2014.06.1201

7. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298(6676):784–788. https://doi.org/10.1136/bmj.298.6676.784

8. Moosazadeh M, Ebrahimnejad P, Kheradmand M, Modanloo M, Mardanshah F, Mahboobi S, et al. Association between smoking and lipid profile in men aged 35 to 70 years: dose-response analysis. Am J Mens Health. 2024;18(3):15579883241249655. https://doi.org/10.1177/15579883241249655

9. Sultan S, Lesloom F. Association of cigarette smoking with cardiometabolic risk factors: a cross-sectional study. Tob Induc Dis. 2024;22:136. https://doi.org/10.18332/tid/191246

10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. https://doi.org/10.1093/clinchem/18.6.499

11. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–xi, 1–253.

12. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoprotein causes atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–2472. https://doi.org/10.1093/eurheartj/exh144

13. Yusuf S, Hawken S, Onupuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–1649. https://doi.org/10.1016/S0140-6736(05)67663-5

14. Audrain-McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther. 2011;90(1):164–168. https://doi.org/10.1038/clpt.2011.105

15. Gelman A, Stern H. The difference between “significant” and “not significant” is not itself statistically significant. Am Stat. 2006;60(4):328–331. https://doi.org/10.1198/000313006X152649

16. Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 2012;380(9841):572–580. https://doi.org/10.1016/S0140-6736(12)60312-2

17. Rohatgi A, Khera A, Berry JD, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383–2393. https://doi.org/10.1056/NEJMoa1409065

18. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237–269. https://doi.org/10.1093/eurheartj/ehz462

19. Wasserstein RL, Lazar NA. The ASA’s statement on p-values: context, process, and purpose. Am Stat. 2016;70(2):129–133. https://doi.org/10.1080/00031305.2016.1514108

20. Pitt B, Loscalzo J, Ycas J, Raichlen JS. Lipid levels after acute coronary syndromes. J Am Coll Cardiol. 2008;51(15):1440–1445. https://doi.org/10.1016/j.jacc.2007.11.075

21. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. https://doi.org/10.1371/journal.pmed.0040296

22. Wu AD, Lindsay N, Hartmann-Boyce J, et al. Smoking cessation for secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2022;8:CD014936. https://doi.org/10.1002/14651858.CD014936.pub2

Downloads

Published

2026-03-23

How to Cite

Fakhre Islam, Qismat Ullah, Farman Ullah, Muhammad Bilal Shah, Ahmad Ehsan Rabani, & Faisal Nadeem. (2026). COMPARISON OF BMI, LIPID PARAMETERS, AST, AND LDH IN MYOCARDIAL INFARCTION PATIENTS STRATIFIED BY SMOKING STATUS: A CASE-CONTROL STUDY PAKISTAN. Journal of Population Therapeutics and Clinical Pharmacology, 33(1), 1390-1399. https://doi.org/10.67145/xbbn9670
More Citation Formats

Issue

Section

Articles

How to Cite

Fakhre Islam, Qismat Ullah, Farman Ullah, Muhammad Bilal Shah, Ahmad Ehsan Rabani, & Faisal Nadeem. (2026). COMPARISON OF BMI, LIPID PARAMETERS, AST, AND LDH IN MYOCARDIAL INFARCTION PATIENTS STRATIFIED BY SMOKING STATUS: A CASE-CONTROL STUDY PAKISTAN. Journal of Population Therapeutics and Clinical Pharmacology, 33(1), 1390-1399. https://doi.org/10.67145/xbbn9670